Publications by authors named "Charlie Bu"

Claim this Profile
D
Development of a Novel DNA Mono-alkylator Platform for Antibody-Drug Conjugates.
Joshua D Thomas, Aleksandr V Yurkovetskiy, Mao Yin, Natalya D Bodyak, Shuyi Tang, Charlie Bu

Mol Cancer Ther· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
Zilucoplan, a macrocyclic peptide inhibitor of human complement component 5, uses a dual mode of action to prevent terminal complement pathway activation.
Guo-Qing Tang, Yalan Tang, Ketki Dhamnaskar, Michelle D Hoarty, Rohit Vyasamneni, Charlie Bu

Front Immunol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum: Zilucoplan, a macrocyclic peptide inhibitor of human complement component 5, uses a dual mode of action to prevent terminal complement pathway activation.
Guo-Qing Tang, Yalan Tang, Ketki Dhamnaskar, Michelle D Hoarty, Rohit Vyasamneni, Charlie Bu

Front Immunol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dolaflexin: A Novel Antibody-Drug Conjugate Platform Featuring High Drug Loading and a Controlled Bystander Effect.
Aleksandr V Yurkovetskiy, Natalya D Bodyak, Mao Yin, Joshua D Thomas, Susan M Clardy, Charlie Bu

Mol Cancer Ther· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Dolaflexin-based Antibody-Drug Conjugate XMT-1536 Targets the Solid Tumor Lineage Antigen SLC34A2/NaPi2b.
Natalya D Bodyak, Rebecca Mosher, Aleksandr V Yurkovetskiy, Mao Yin, Charlie Bu

Mol Cancer Ther· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of IDX184, a liver-targeted oral prodrug of 2'-methylguanosine-5'-monophosphate, in the monkey and formulation optimization for human exposure.
Xin-Ru Pan-Zhou, Benjamin A Mayes, Hassan Rashidzadeh, Rahela Gasparac, Steven Smith, Charlie Bu

Eur J Drug Metab Pharmacokinet· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis